Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Offices

New Haven, USA
5 Science Park
401 Winchester Avenue
New Haven, CT, 06511
USA

People

Board of Directors
Board of Directors
Board of Directors
Board of Directors
Board of Directors
Board of Directors

Funding

TOTAL $38.3M
FUNDING TOTAL $38.3M
Series A, 6/2007
CHL Medical Partners
Novartis Venture Fund
Elm Street Ventures
New Leaf Venture Partners
Aisling Capital
Alexandria Real Estate Equities
$25.8M
Series A, 1/2010
$5.54M
Venture Round, 9/2011
$3.6M
Venture Round, 1/2012
$500k
Venture Round, 3/2012
Brian Dixon
New Leaf Venture Partners
OpGen
Novartis Venture Fund
$2.56M
Venture Round, 4/2012
Connecticut Innovations
$269k
DEBT TOTAL $2.4M
Debt, 12/2010
$2.4M

Tags

BioRelix

BioRelix, Inc., a biopharmaceutical company, engages in the discovery and development of anti-biotic drug candidates for the treatment of infectious diseases in the United States. It develops a portfolio of riboswitch-based therapeutic agents to overcome the lethal and devastating causes of bacterial infections. The company was founded in 2005 and is based in New Haven, Connecticut.

Recent Milestones

Videos

Screenshots

Sources

  1. Nutmeg State biotech lands $25.8M in round one (masshightech.com) [edit]
  2. SEC (sec.gov) [edit]
  3. BioRelix lands $2.4M financing (masshightech.com) [edit]
  4. BioRelix lands $3.6M to treat infectious diseases (masshightech.com) [edit]
  5. Conn. antibiotics maker BioRelix rounds up $500K (masshightech.com) [edit]
  6. Connecticut biotech raises $2.56M round (masshightech.com) [edit]
  7. BioRelix Receives $269K Follow-on Investment from Connecticut Innovations (finsmes.com) [edit]
Edit This Page
Last Edited 12/19/13

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy